Wu-Sung Ki
Chief Executive Officer at CELLTRION, INC.
Net worth: 24 M $ as of 29/06/2025
Profile
Wu-Sung Ki is currently the Chief Executive Officer & Director at Celltrion, Inc. He previously held positions as the Chief Executive Officer & Director at Celltrion Healthcare Co., Ltd. and as the Vice President at Celltrion Skincure Co., Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
CELLTRION, INC. 0.09% | 02/07/2025 | 204,120 ( 0.09% ) | 24 M $ | 29/06/2025 |
Latest news about Wu-Sung Ki
Wu-Sung Ki active positions
Companies | Position | Start |
---|---|---|
CELLTRION, INC. | Chief Executive Officer | 19/03/2015 |
Former positions of Wu-Sung Ki
Companies | Position | End |
---|---|---|
Celltrion Skincure Co., Ltd.
![]() Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Director/Board Member | 14/10/2014 |
CELLTRION HEALTHCARE CO., LTD. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CELLTRION, INC. | Health Technology |
Private companies | 2 |
---|---|
Celltrion Healthcare Co., Ltd.
![]() Celltrion Healthcare Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion Healthcare Co., Ltd. manufactures pharmaceutical products. Its products include infliximab, rituximab, and trastuzumab biosimilars. The company was founded on December 29, 1999 and is headquartered in Incheon, South Korea. | Health Technology |
Celltrion Skincure Co., Ltd.
![]() Celltrion Skincure Co., Ltd. Pharmaceuticals: MajorHealth Technology Celltrion GSC Co., Ltd. is a holding company, which manufactures pharmaceutical subsidiary materials. It also engages in research and development of pharmaceutical materials and product localization. The company was founded on June 14, 2000 and is headquartered in Incheon, South Korea. | Health Technology |
- Stock Market
- Insiders
- Wu-Sung Ki